Pages that link to "Q34533170"
Jump to navigation
Jump to search
The following pages link to Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma (Q34533170):
Displaying 50 items.
- Smoking, environmental tobacco smoke, and risk of renal cell cancer: a population-based case-control study (Q21260395) (← links)
- Expression of the ammonia transporter, rh C glycoprotein, in normal and neoplastic human kidney (Q24300575) (← links)
- B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival (Q24550945) (← links)
- Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target (Q24559442) (← links)
- Accurate molecular classification of renal tumors using microRNA expression (Q24625843) (← links)
- Histological reclassification, histochemical characterization and c-kit immunoexpression in renal cell carcinoma (Q24658263) (← links)
- Review of renal cell carcinoma and its common subtypes in radiology (Q26744297) (← links)
- Thyroid Hormones as Renal Cell Cancer Regulators (Q26748991) (← links)
- Renal cell carcinoma: histological classification and correlation with imaging findings (Q26799781) (← links)
- New magnetic resonance imaging methods in nephrology (Q26866166) (← links)
- Targeted therapies and the treatment of non-clear cell renal cell carcinoma (Q26995391) (← links)
- Emerging critical role of molecular testing in diagnostic genitourinary pathology (Q27021371) (← links)
- Circulating biomarkers in advanced renal cell carcinoma: clinical applications (Q27023770) (← links)
- A case-control study of occupation/industry and renal cell carcinoma risk (Q28391235) (← links)
- Contrast enhanced ultrasound of renal masses (Q30478161) (← links)
- Clinical applications of diffusion-weighted magnetic resonance imaging in diagnosis of renal lesions - a systematic review (Q31030957) (← links)
- Magnetic resonance imaging as a biomarker in renal cell carcinoma (Q33436273) (← links)
- Pathway signature and cellular differentiation in clear cell renal cell carcinoma (Q33587345) (← links)
- Tetravalent antibody-scTRAIL fusion proteins with improved properties (Q33619046) (← links)
- Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies (Q33636256) (← links)
- Genome-wide association study identifies multiple risk loci for renal cell carcinoma (Q33804470) (← links)
- AIF downregulation and its interaction with STK3 in renal cell carcinoma. (Q33843217) (← links)
- Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma (Q33907163) (← links)
- Non-clear cell renal cancer: disease-based management and opportunities for targeted therapeutic approaches (Q34194075) (← links)
- Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions (Q34206531) (← links)
- Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma (Q34217704) (← links)
- Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors (Q34228845) (← links)
- Solid renal masses: what the numbers tell us. (Q34241434) (← links)
- Heterogeneity and renal mass biopsy: a review of its role and reliability (Q34340943) (← links)
- Tumor classification by tissue microarray profiling: random forest clustering applied to renal cell carcinoma (Q34365572) (← links)
- Targeted therapies for non-clear renal cell carcinoma (Q34412479) (← links)
- Clinical significance of heparanase splice variant (t5) in renal cell carcinoma: evaluation by a novel t5-specific monoclonal antibody (Q34516760) (← links)
- Prognostic ability of simplified nuclear grading of renal cell carcinoma (Q34574526) (← links)
- Changes in clinicopathological characteristics of renal cell carcinoma in the past 25 years: a single-center experience (Q34609828) (← links)
- Targeted therapies in the management of renal cell carcinoma: role of bevacizumab (Q34611205) (← links)
- Implication of snail in metabolic stress-induced necrosis (Q34713056) (← links)
- Coexistence of a colon carcinoma with two distinct renal cell carcinomas: a case report. (Q34809083) (← links)
- Comparisons of three polyethyleneimine-derived nanoparticles as a gene therapy delivery system for renal cell carcinoma (Q35027211) (← links)
- Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma (Q35074682) (← links)
- MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma (Q35090735) (← links)
- Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implications (Q35137857) (← links)
- Relating prognosis in chromophobe renal cell carcinoma to the chromophobe tumor grading system. (Q35150993) (← links)
- Renal cell carcinoma and the use of sorafenib (Q35166782) (← links)
- Impact of genetics on the diagnosis and treatment of renal cancer (Q35189579) (← links)
- Current staging of renal cell carcinoma (Q35210978) (← links)
- Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies (Q35315403) (← links)
- The value of blood oxygenation level-dependent (BOLD) MR imaging in differentiation of renal solid mass and grading of renal cell carcinoma (RCC): analysis based on the largest cross-sectional area versus the entire whole tumour (Q35431606) (← links)
- Systemic adjuvant therapies in renal cell carcinoma (Q35569322) (← links)
- Prognostic relevance of extensive necrosis in renal cell carcinoma (Q35588266) (← links)
- MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs (Q35621551) (← links)